Modulation of Urate Transport by Drugs

Modulation of Urate Transport by Drugs

Background: Serum urate (SU) levels in primates are extraordinarily high among mammals. Urate is a Janus-faced molecule that acts physiologically as a protective antioxidant but provokes inflammation and gout when it precipitates at high concentrations. Transporters play crucial roles in urate dispo...

Full description

Bibliographic Details
Main Authors:	Péter Tátrai, Franciska Erdő, Gabriella Dörnyei, Péter Krajcsi
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Pharmaceutics
Subjects:	urate drug-transporter interactions in vitro prediction hyperuricemia hypouricemia
Online Access:	https://www.mdpi.com/1999-4923/13/6/899

Similar Items

Hypouricemia and Urate Transporters
by: Naoyuki Otani, et al.
Published: (2022-03-01)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
by: Péter Tátrai, et al.
Published: (2022-12-01)

A System for Discovering Novel Uricosurics Targeting Urate Transporter 1 Based on In Vitro and In Vivo Modeling
by: Xuechen Li, et al.
Published: (2024-01-01)

A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice
by: Yanjie Ma, et al.
Published: (2017-10-01)

Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan
by: Masafumi Kurajoh, et al.
Published: (2024-01-01)

Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01)

Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats
by: Yanzuo Le, et al.
Published: (2020-12-01)

Uric acid transporter inhibitors for gout
by: Philip K. Tan, et al.
Published: (2017-06-01)

Uricase-Deficient Larval Zebrafish with Elevated Urate Levels Demonstrate Suppressed Acute Inflammatory Response to Monosodium Urate Crystals and Prolonged Crystal Persistence
by: Tanja Linnerz, et al.
Published: (2022-11-01)

Renal effects of uric acid: hyperuricemia and hypouricemia
by: Jung Hwan Park, et al.
Published: (2020-11-01)

Functional Characterization of Rare Variants in OAT1/<i>SLC22A6</i> and OAT3/<i>SLC22A8</i> Urate Transporters Identified in a Gout and Hyperuricemia Cohort
by: Jiří Vávra, et al.
Published: (2022-03-01)

Research progress on related factors of pathogenicity of urate crystals in patients with asymptomatic hyperuricemia
by: Zhong Yang, Wang Lijuan, Wang Yuanli, Li Yasong
Published: (2022-02-01)

Konjac glucomannan improves hyperuricemia through regulating xanthine oxidase, adenosine deaminase and urate transporters in rats
by: Yuan Zhang, et al.
Published: (2018-09-01)

Pu-erh ripened tea resists to hyperuricemia through xanthine oxidase and renal urate transporters in hyperuricemic mice
by: Ran Zhao, et al.
Published: (2017-02-01)

Pathogenic Variants of <i>SLC22A12</i> (URAT1) and <i>SLC2A9</i> (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of <i>SLC2A9</i> Variant c.374C>T; p.(T125M)
by: Ana Perdomo-Ramirez, et al.
Published: (2023-05-01)

Genetic Basis of the Epidemiological Features and Clinical Significance of Renal Hypouricemia
by: Masayuki Hakoda, et al.
Published: (2022-07-01)

Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1
by: Dool-Ri Oh, et al.
Published: (2019-01-01)

Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia
by: Blanka Stiburkova, et al.
Published: (2019-08-01)

Distribution of serum uric acid levels and prevalence of hyper- and hypouricemia in a Korean general population of 172,970
by: Bon San Koo, et al.
Published: (2021-03-01)

Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors
by: Xianxin Hou, et al.
Published: (2023-11-01)

Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01)

Hipouricemia con hipercalciuria. Estudio longitudinal y revisión del tema
by: Teresa Moraleda Mesa, et al.
Published: (2024-03-01)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
by: Rebekah Wrigley, et al.
Published: (2020-03-01)

A heterozygous variant in the SLC22A12 gene in a Sri Lanka family associated with mild renal hypouricemia
by: Dinesha Maduri Vidanapathirana, et al.
Published: (2018-06-01)

Polydatin alleviates hyperuricemia combined with gouty arthritis in mice via regulating urate transporters, NLRP3 inflammasome and NF-κB pathway
by: Wenjing Xu, et al.
Published: (2023-06-01)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
by: Zijing Ran, et al.
Published: (2021-09-01)

Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1/ERK/MMP-9 signaling pathway
by: Jen-Chun Wang, et al.
Published: (2023-01-01)

Disorder of purine metabolism in the etiopathogenesis of urate nephrolithiasis
by: S. I. Vorotyntsev, et al.
Published: (2023-04-01)

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
by: Blanka Stiburkova, et al.
Published: (2019-03-01)

Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials
by: Toshinari Takahashi, et al.
Published: (2021-11-01)

Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)
by: Atsushi Tanaka, et al.
Published: (2023-07-01)

Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson’s disease
by: Li-Hui Bao, et al.
Published: (2018-05-01)

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
by: Aleš Kvasnička, et al.
Published: (2023-12-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia
by: Mo Chen, et al.
Published: (2020-07-01)

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
by: Bendong Yang, et al.
Published: (2022-11-01)

Advances in Urate Excretion and Urate Transporters in Hyperuricemia
by: XIN Jiadong, ZHOU Jiabao, WU Zhiyuan, ZHANG Xuming, GAO Jiandong
Published: (2023-05-01)

New <i>SLC22A12</i> (URAT1) Variant Associated with Renal Hypouricemia Identified by Whole-Exome Sequencing Analysis and Bioinformatics Predictions
by: Ana Perdomo-Ramírez, et al.
Published: (2023-09-01)

A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
by: Hidekatsu Yanai, et al.
Published: (2024-03-01)

Gender-Specific Inverse Associations Between Beans Intake, Serum Urate Levels, and Hyperuricemia: A Cross-Sectional Analysis Based on the Henan Rural Cohort Study
by: Ningning Cui, et al.
Published: (2021-01-01)